
|Videos|January 18, 2023
Factors for Consideration When Selecting Treatments for Patients with mCRPC
Author(s)Stephen J. Freedland, MD
Stephen J. Freedland, MD, explains the treatment regimen he would have chosen for the patient with mCRPC in the presented case and outlines which factors, including clinical data, inform his treatment decision-making.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC
2
Jessica Yih, MD, highlights data on testosterone therapy in women
3
Blue light cystoscopy is tied to higher resource use, not health care cost, in NMIBC
4
The AUA Clinically Localized Prostate Cancer guideline: FAQs for urologists
5







